4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0001706176-26-000004
Chief Financial Officer bought 7,500 shares at $8.57 ($64,275)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chevallard Daniel R. Chief Financial Officer | 2026-03-27 | Purchase | +7,500 | $8.57 | $64,275 | 12,886 | D |
| Open-market purchases · 7,500 sh · avg $8.57 · $64,275 | |||||||
Loading xslF345X06/wk-form4_1774874809.xml…